Federal Court Upholds Michigan’s Newborn Screening Program
Update: Jun 25-Jul 7, 2025
The U.S. Court of Appeals has ruled to uphold the constitutionality of Michigan’s Newborn Screening Program, allowing our state to continue one of its most critical public health efforts. This decision came when the Sixth Circuit Court of Appeals reversed a lower court ruling and confirmed that the state’s collection and use of de-identified newborn blood samples, used to screen for over 50 potentially life-threatening conditions, does not infringe on constitutional rights. The ruling also protects the BioTrust for Health, a research initiative that supports medical advancement through the use of privacy-protected samples.
Attorney General Dana Nessel and Michigan Department of Health and Human Services (MDHHS) Director Elizabeth Hertel both praised the decision as a win for families across the state. Since its launch in 1965, the Newborn Screening Program has enabled early diagnosis and treatment for thousands of Michigan infants who might otherwise have gone undiagnosed. With the court’s ruling, the program can continue to detect rare disorders in their earliest stages— when intervention is most effective— while also supporting responsible medical research that may benefit future generations.